Clinical Trial Update: A Trial of GH001 in Patients With Treatment-resistant Depression [Phase 2]

View source ↗

Summary

GH Research Ireland Limited has completed a Phase 2 trial evaluating GH001 in patients with treatment-resistant depression.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Treatment-resistant Depression

Drugs mentioned

• GH001

Snippet

Sponsor: GH Research Ireland Limited | Conditions: Treatment-resistant Depression | Phase 2 | Status: COMPLETED